LR11, A NOVEL CIRCULATING MARKER OF CAROTID ATHEROSCLEROSIS, IS ESSENTIAL FOR ANGIOTENSIN II-INDUCED INTIMAL SMOOTH MUSCLE CELL MIGRATION

被引:0
|
作者
Bujo, H. [1 ]
Jiang, M. [1 ]
Ohwaki, K. [2 ]
Schneider, W. [3 ]
Saito, Y. [2 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chiba, Japan
[3] Univ Vienna, Bioctr, Dept Mol Genet, Vienna, Austria
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Circulating sLR11, Essential for the Angiotensin II-Induced Intimal Smooth Muscle Cell Migration, Is a Biomarker of Carotid Atherosclerosis
    Bujo, Hideaki
    Jiang, Meizi
    Ohwaki, Kenji
    Saito, Yasushi
    DIABETES, 2009, 58 : A202 - A202
  • [2] A soluble form of Ldl receptor gene family member, Lr11, is essential for angiotensin II-induced Smc migration
    Pang, Meizi
    Bujo, Hideaki
    Ohwaki, Kenji
    Takahashi, Mao
    Shirai, Kohji
    Schneider, Wolfgang J.
    Saito, Yasushi
    CIRCULATION, 2007, 116 (16) : 298 - 298
  • [3] ENHANCED CIRCULATING SOLUBLE LR11 AFTER CORONARY STENTING, A NOVEL MARKER OF SMOOTH MUSCLE CELL MIGRATION IN RESPONSE TO VASCULAR INJURY
    Ogita, Manabu
    Miyauchi, Katsumi
    Jiang, Meizi
    Tsuboi, Shuta
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Kasai, Takatoshi
    Bujo, Hideaki
    Daida, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1138 - E1138
  • [4] Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes
    Jin, Wenlong
    Jiang, Meizi
    Han, Xinhua
    Han, Xuehua
    Murano, Takeyoshi
    Hiruta, Nobuyuki
    Ebinuma, Hiroyuki
    Piao, Lianshan
    Schneider, Wolfgang J.
    Bujo, Hideaki
    CLINICA CHIMICA ACTA, 2016, 457 : 137 - 141
  • [5] Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis
    Harada, Masashi
    Jiang, Meizi
    Terai, Kensuke
    Ebinuma, Hiroyuki
    Hiruta, Nobuyuki
    Schneider, Wolfgang J.
    Sugo, Nobuo
    Nagao, Takeki
    Bujo, Hideaki
    CLINICA CHIMICA ACTA, 2019, 490 : 69 - 76
  • [6] Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury
    Ogita, Manabu
    Miyauchi, Katsumi
    Jiang, Meizi
    Kasai, Takatoshi
    Tsuboi, Shuta
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Yokoyama, Takayuki
    Okazaki, Shinya
    Shimada, Kazunori
    Bujo, Hideaki
    Daida, Hiroyuki
    ATHEROSCLEROSIS, 2014, 237 (01) : 374 - 378
  • [7] LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration
    Zhu, YJ
    Bujo, H
    Yamazaki, H
    Ohwaki, K
    Jiang, MZ
    Hirayama, S
    Kanaki, T
    Shibasaki, M
    Takahashi, K
    Schneider, WJ
    Saito, Y
    CIRCULATION RESEARCH, 2004, 94 (06) : 752 - 758
  • [8] Gene targeting of LR11, a regulator of migration of intimal smooth muscle cells, drastically reduces intimal thickness of injured artery mice
    Jiang, Meizi
    Bujo, Hideaki
    Ohwaki, Kenji
    Schneider, Wolfgang J.
    Unoki, Hiroyuki
    Saito, Yasushi
    CIRCULATION, 2006, 114 (18) : 266 - 266
  • [9] Circulating levels of soluble form of LR11, a novel migration regulator of intimal SMC, are increased in subjects with coronary stenosis
    Takahashi, Mao
    Bujo, Hideaki
    Jiang, Meiji
    Ohwaki, Kenji
    Noike, Hirofumi
    Schneider, Wolfagang J.
    Salto, Yasushi
    Shirai, Kohji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A296 - A296
  • [10] Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice
    Jiang, Meizi
    Bujo, Hideaki
    Ohwaki, Kenji
    Unoki, Hiroyuki
    Yamazaki, Hiroyuki
    Kanaki, Tatsuro
    Shibasaki, Manabu
    Azuma, Kazuhiko
    Harigaya, Kenichi
    Schneider, Wolfgang J.
    Saito, Yasushi
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (08): : 2733 - 2746